A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study.

Détails

Ressource 1Télécharger: 33163952_BIB_E48BB8C87F06.pdf (2654.71 [Ko])
Etat: Public
Version: Author's accepted manuscript
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_E48BB8C87F06
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study.
Périodique
The Lancet. Digital health
Auteur⸱e⸱s
Lu C., Bera K., Wang X., Prasanna P., Xu J., Janowczyk A., Beig N., Yang M., Fu P., Lewis J., Choi H., Schmid R.A., Berezowska S., Schalper K., Rimm D., Velcheti V., Madabhushi A.
ISSN
2589-7500 (Electronic)
ISSN-L
2589-7500
Statut éditorial
Publié
Date de publication
11/2020
Peer-reviewed
Oui
Volume
2
Numéro
11
Pages
e594-e606
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
Intratumoural heterogeneity has been previously shown to be related to clonal evolution and genetic instability and associated with tumour progression. Phenotypically, it is reflected in the diversity of appearance and morphology within cell populations. Computer-extracted features relating to tumour cellular diversity on routine tissue images might correlate with outcome. This study investigated the prognostic ability of computer-extracted features of tumour cellular diversity (CellDiv) from haematoxylin and eosin (H&E)-stained histology images of non-small cell lung carcinomas (NSCLCs).
In this multicentre, retrospective study, we included 1057 patients with early-stage NSCLC with corresponding diagnostic histology slides and overall survival information from four different centres. CellDiv features quantifying local cellular morphological diversity from H&E-stained histology images were extracted from the tumour epithelium region. A Cox proportional hazards model based on CellDiv was used to construct risk scores for lung adenocarcinoma (LUAD; 270 patients) and lung squamous cell carcinoma (LUSC; 216 patients) separately using data from two of the cohorts, and was validated in the two remaining independent cohorts (comprising 236 patients with LUAD and 335 patients with LUSC). We used multivariable Cox regression analysis to examine the predictive ability of CellDiv features for 5-year overall survival, controlling for the effects of clinical and pathological parameters. We did a gene set enrichment and Gene Ontology analysis on 405 patients to identify associations with differentially expressed biological pathways implicated in lung cancer pathogenesis.
For prognosis of patients with early-stage LUSC, the CellDiv LUSC model included 11 discriminative CellDiv features, whereas for patients with early-stage LUAD, the model included 23 features. In the independent validation cohorts, patients predicted to be at a higher risk by the univariable CellDiv model had significantly worse 5-year overall survival (hazard ratio 1·48 [95% CI 1·06-2·08]; p=0·022 for The Cancer Genome Atlas [TCGA] LUSC group, 2·24 [1·04-4·80]; p=0·039 for the University of Bern LUSC group, and 1·62 [1·15-2·30]; p=0·0058 for the TCGA LUAD group). The identified CellDiv features were also found to be strongly associated with apoptotic signalling and cell differentiation pathways.
CellDiv features were strongly prognostic of 5-year overall survival in patients with early-stage NSCLC and also associated with apoptotic signalling and cell differentiation pathways. The CellDiv-based risk stratification model could potentially help to determine which patients with early-stage NSCLC might receive added benefit from adjuvant therapy.
National Institue of Health and US Department of Defense.
Pubmed
Web of science
Open Access
Oui
Création de la notice
11/11/2020 8:43
Dernière modification de la notice
30/04/2021 7:15
Données d'usage